Michael Scolaro

Michael Scolaro

Sep 18, 2017

Group 6 Copy 56
0
    Please wait...

    About This Project

    We hypothesize that targeted delivery of Curcumin to antigen presenting cells in the immune system can suppress tumor growth for a variety of cancers. This study will examine tumor responses to Curcumin in a colon cancer mouse model when given alone or in combination with an FDA-approved immune Checkpoint Inhibitor. Positive results will lead to Fast-Track FDA applications for human and companion pet animal cancer trials.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    Does Zika virus suppress the antiviral host response in neuronal cells?

    Zika virus is spreading rapidly in the Western hemisphere and is linked to fetal microcephaly. We recently...

    From Minerals to Medicines: A New Technology for Heavy Metal Pollution Remediation

    This is the first part of a multi-phase experiment in which I will prove that substances isolated from plant...

    Backer Badge Funded